Ispecimen Inc (ISPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -4,652 | -3,059 | -1,812 | -4,727 |
| Depreciation Amortization | 963 | 775 | 588 | 1,187 |
| Accounts receivable | N/A | -794 | -464 | N/A |
| Accounts payable and accrued liabilities | N/A | 474 | 146 | N/A |
| Other Working Capital | 3,041 | 1,864 | 1,206 | 1,051 |
| Other Operating Activity | 360 | 476 | 391 | -191 |
| Operating Cash Flow | $-288 | $-264 | $56 | $-2,680 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | 0 | -866 | -592 | -28 |
| Other Investing Activity | -1,103 | 0 | 0 | -1,447 |
| Investing Cash Flow | $-1,103 | $-866 | $-592 | $-1,475 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 2,033 | 1,783 | N/A |
| Other Financing Activity | 2,033 | 0 | 0 | 3,079 |
| Financing Cash Flow | $2,033 | $2,033 | $1,783 | $3,079 |
| Beginning Cash Position | 54 | 54 | 54 | 1,130 |
| End Cash Position | 696 | 957 | 1,301 | 54 |
| Net Cash Flow | $642 | $903 | $1,247 | $-1,076 |
| Free Cash Flow | ||||
| Operating Cash Flow | -288 | -264 | 56 | -2,680 |
| Capital Expenditure | N/A | -866 | -592 | N/A |
| Free Cash Flow | -288 | -1,130 | -536 | -2,680 |